Consequent pharmacological inhibition of the ATM pathway restored the tumor’s radiosensitivity, suggesting the translational potential to improve radiotherapy outcomes for patients with IDH1 gliomas harboring similar mutations. The gene discussed is IDH1; the disease is central nervous system cancer.